EWTX logo

Edgewise Therapeutics (EWTX) Selling, general & administrative expenses

annual SGA:

$31.87M+$8.41M(+35.88%)
December 31, 2024

Summary

  • As of today (July 6, 2025), EWTX annual SGA is $31.87 million, with the most recent change of +$8.41 million (+35.88%) on December 31, 2024.
  • During the last 3 years, EWTX annual SGA has risen by +$20.84 million (+189.01%).
  • EWTX annual SGA is now at all-time high.

Performance

EWTX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

quarterly SGA:

$9.20M+$32.00K(+0.35%)
March 31, 2025

Summary

  • As of today (July 6, 2025), EWTX quarterly SGA is $9.20 million, with the most recent change of +$32.00 thousand (+0.35%) on March 31, 2025.
  • Over the past year, EWTX quarterly SGA has increased by +$2.14 million (+30.36%).
  • EWTX quarterly SGA is now at all-time high.

Performance

EWTX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

TTM SGA:

-$1.44B-$146.09M(-11.28%)
March 31, 2025

Summary

  • As of today (July 6, 2025), EWTX TTM SGA is -$1.44 billion, with the most recent change of -$146.09 million (-11.28%) on March 31, 2025.
  • Over the past year, EWTX TTM SGA has dropped by -$1.47 billion (-5940.66%).
  • EWTX TTM SGA is now -4121.89% below its all-time high of -$34.15 million.

Performance

EWTX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

EWTX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.9%+30.4%-5940.7%
3 y3 years+189.0%+148.6%-10000.0%
5 y5 years+2351.2%+3174.7%-10000.0%

EWTX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+189.0%at high+125.0%-323.4%at low
5 y5-yearat high+2351.2%at high+2793.7%-4121.9%at low
alltimeall timeat high+2351.2%at high+3174.7%-4121.9%at low

EWTX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$9.20M(+0.3%)
$34.01M(+6.7%)
Dec 2024
$31.87M(+35.9%)
$9.17M(+11.7%)
$31.87M(+10.4%)
Sep 2024
-
$8.21M(+10.5%)
$28.87M(+9.7%)
Jun 2024
-
$7.43M(+5.2%)
$26.33M(+6.7%)
Mar 2024
-
$7.06M(+14.3%)
$24.68M(+5.2%)
Dec 2023
$23.45M(+33.1%)
$6.18M(+9.0%)
$23.45M(+3.1%)
Sep 2023
-
$5.67M(-2.0%)
$22.74M(+6.1%)
Jun 2023
-
$5.78M(-0.8%)
$21.44M(+8.6%)
Mar 2023
-
$5.83M(+6.6%)
$19.75M(+12.1%)
Dec 2022
$17.63M
$5.47M(+25.2%)
$17.63M(+10.9%)
Sep 2022
-
$4.37M(+6.8%)
$15.89M(+8.0%)
DateAnnualQuarterlyTTM
Jun 2022
-
$4.09M(+10.5%)
$14.72M(+11.3%)
Mar 2022
-
$3.70M(-0.9%)
$13.23M(+20.0%)
Dec 2021
$11.03M(+399.1%)
$3.73M(+16.8%)
$11.03M(+29.8%)
Sep 2021
-
$3.20M(+23.0%)
$8.50M(+48.9%)
Jun 2021
-
$2.60M(+73.6%)
$5.71M(+66.6%)
Mar 2021
-
$1.50M(+24.2%)
$3.42M(+55.0%)
Dec 2020
$2.21M(+69.9%)
$1.21M(+197.5%)
$2.21M(+120.0%)
Sep 2020
-
$405.00K(+27.4%)
$1.00M(+67.6%)
Jun 2020
-
$318.00K(+13.2%)
$599.00K(+113.2%)
Mar 2020
-
$281.00K
$281.00K
Dec 2019
$1.30M
-
-

FAQ

  • What is Edgewise Therapeutics annual SGA?
  • What is the all time high annual SGA for Edgewise Therapeutics?
  • What is Edgewise Therapeutics annual SGA year-on-year change?
  • What is Edgewise Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Edgewise Therapeutics?
  • What is Edgewise Therapeutics quarterly SGA year-on-year change?
  • What is Edgewise Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Edgewise Therapeutics?
  • What is Edgewise Therapeutics TTM SGA year-on-year change?

What is Edgewise Therapeutics annual SGA?

The current annual SGA of EWTX is $31.87M

What is the all time high annual SGA for Edgewise Therapeutics?

Edgewise Therapeutics all-time high annual SGA is $31.87M

What is Edgewise Therapeutics annual SGA year-on-year change?

Over the past year, EWTX annual SGA has changed by +$8.41M (+35.88%)

What is Edgewise Therapeutics quarterly SGA?

The current quarterly SGA of EWTX is $9.20M

What is the all time high quarterly SGA for Edgewise Therapeutics?

Edgewise Therapeutics all-time high quarterly SGA is $9.20M

What is Edgewise Therapeutics quarterly SGA year-on-year change?

Over the past year, EWTX quarterly SGA has changed by +$2.14M (+30.36%)

What is Edgewise Therapeutics TTM SGA?

The current TTM SGA of EWTX is -$1.44B

What is the all time high TTM SGA for Edgewise Therapeutics?

Edgewise Therapeutics all-time high TTM SGA is -$34.15M

What is Edgewise Therapeutics TTM SGA year-on-year change?

Over the past year, EWTX TTM SGA has changed by -$1.47B (-5940.66%)
On this page